ArcanaBio, a Copenhagen, Denmark-based biotech company developing developing diagnostic technologies, raised funding from BioInnovative Institute (BII).
The amount of the deal was not disclosed.
The company intends to use the funds to expand operations and its R&D sector.
Led by CEO Kristjan Gunnarsson, ArcanaBio is a biotech company dedicated to developing diagnostic technologies, with a focus on nano-photonics and biosensors. The company aims to bring laboratory-grade testing into everyday environments, empowering individuals to take charge of their health. Leveraging novel nano-photonics technology coupled with AI, its liquid biopsy solution aims to enable the protein characterization, bringing reference-grade diagnostics to the home.
ArcanaBio will join BII’s Deep Tech Lab – Quantum program in Copenhagen from September 2024.
FinSMEs
09/09/2024